Arena Ready For FDA To Reconsider Weight-Loss Drug Lorcaserin
This article was originally published in The Pink Sheet Daily
Executive Summary
Arena and Eisai expect to hear in the next week or so whether FDA will accept their answer to an October 2010 “complete response” letter and set a new action date for their novel weight loss drug.